Acarix AB: insider trades · Finland · FIN-FSA FI:acarix-ab SE0009268717 FI FI · FIN-FSA Mcap 303M€ Healthcare
Discover the full management transaction log of Acarix AB, a listed equity based in Finland. Shares are listed on FI FI, under the supervision of FIN-FSA. Operating in the Healthcare sector, Acarix AB has published 5 reports. Market capitalisation: €302.8m. The latest transaction was reported on 22 September 2025 — Purchase. Among the most active insiders: Aamir Mahmood. The full history is openly available.
Financial data FY ended December 2025 · cache
Analyst consensus
1 analysts · 0.40 € Target 0.40 €(+54%) 0.40 €
Income statement
Revenue 7.4 M€
Gross profit 6.2 M€ 85% margin
Net income −48.1 M€ -653.3% margin
Balance sheet & cash
Market cap 302.8 M€
Free Cash Flow −38.0 M€
Profitability & ownership
ROE -84.5%
ROA -46.5%
% insiders 15.3%
% institutions 1.3%
Last declaration on 22 September 2025
Declarations 5 total
Executives ● Purchase15 FIN-FSA
€4,065 150,000 shares @ €0.0271 0.0013% mcap 100.0% of flow SE0009268717⌘
Aktie
FI:A003S480-1 · 17 Sept 2025
Ideal exit: 14 Jun 2026 (T+270) Executives ● Purchase26 FIN-FSA
€10,140 385,553 shares @ €0.0263 0.0033% mcap 14.9% of flow SE0009268717⌘
Aktie
FI:A003S110-1 · 5 Sept 2025
Ideal exit: 2 Jun 2026 (T+270) Executives ● Purchase24 FIN-FSA
€14,547 588,753 shares @ €0.0247 0.0048% mcap 21.4% of flow SE0009268717⌘
Aktie
FI:A003H027-2 · 29 Aug 2024
Ideal exit: 26 May 2025 (T+270) Executives ● Purchase27 FIN-FSA
€28,130 1,382,000 shares @ €0.0204 0.0093% mcap 41.4% of flow SE0009268717⌘
Aktie
FI:A003L497-2 · 13 Feb 2025
Ideal exit: 10 Nov 2025 (T+270) Executives ● Purchase24 FIN-FSA
€15,124 751,549 shares @ €0.0201 0.0050% mcap 22.3% of flow SE0009268717⌘
Aktie
FI:A003M644-2 · 12 Mar 2025
Ideal exit: 7 Dec 2025 (T+270)